Latest From Ryan Nelson
Biometric litigation has been stacking up in state and federal courts, including suits targeting cosmetics companies for alleged consumer privacy violations associated with virtual try-on tools. L’Oreal and The Estee Lauder Companies are among the latest to be hit with proposed class actions in Illinois federal court.
Bundled within the draft FDA Safety and Landmark Enhancements Act are federal cosmetics reform provisions that would require facility registration and product listings with the US FDA, adverse event reporting and good manufacturing practices, while empowering the agency to order product recalls, access company records, and suspend dangerous operations.
The European Chemicals Agency is targeting the back half of 2022 for guidance on revised information requirements for substances registered under REACH, following a European Commission regulation published in March.
The New York-based manufacturer of prestige perfumes and cosmetics is “extremely optimistic” about fiscal 2022 and the years ahead, recording net sales growth of 26% in the first quarter, led by major brand innovations, and projecting an 11% increase for the full year.
The SC Johnson brand is providing full refunds to consumers who purchased the chamomile verbena Bubble Bath products, which may contain a bacterium that is potentially harmful to the immunocompromised and those with broken or irritated skin, “such as diaper rash.”
The FDA issued warning letters to a dozen companies about marketing OTC skin-lightening products containing hydroquinone. While the agency’s stance was friendlier toward such products when it launched the OTC drug review program 40 years ago, the program has changed, and so have the FDA’s views on hydroquinone.